Primary cardiac tumors are rare and myxoma constitutes the majority. The present study summarizes our 30-year clinical outcomes of surgical myxoma resection.
Between January 1986 and December 2015, 93 patients (30 men, 63 women; mean age, 54.7 ± 16.6 years) underwent surgical myxoma resection. The most common origin site was the left atrium. Surgery was performed via a biatrial approach in 74.2%, atrial septotomy through right atriotomy in 17.2%, and left atriotomy only in 8.6%. Mean myxoma size based on longest length was 4.73 ± 1.92 cm (range, 1.2–11.0 cm).
The mean follow-up duration was 9.9 ± 7.8 years (range, 0–29 years). In-hospital mortality was 3.2%. The most common postoperative complication was atrial fibrillation (4.3%). The 5-, 10-, and 30-year survival rates were 92.9%, 87.2%, and 75.5%, respectively. Recurrence occurred in two patients (2.1%), which were detected at 20 and 79 months after the first surgery, respectively.
Long-term survival after myxoma resection was excellent and recurrence was rare. Based on our experience, surgical method did not affect the outcome.
Prichard RW. Tumors of the heart; review of the subject and report of 150 cases. AMA Arch Pathol. 1951;51:98–128. PubMed
Gerbode F, Kerth WJ, Hill JD. Surgical management of tumors of the heart. Surgery. 1967;61:94–101. PubMed
- Surgical resection of cardiac myxoma—a 30-year single institutional experience
Kyo Seon Lee
Gwan Sic Kim
In Seok Jeong
Kook Joo Na
Bong Suk Oh
Byung Hee Ahn
Sang Gi Oh
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II